Literature DB >> 32456975

Variation in complications and mortality following ALPPS at early-adopting centers.

Kerollos N Wanis1, Michael Linecker2, Arin L Madenci3, Philip C Müller2, Natascha Nüssler4, Roberto Brusadin5, Ricardo Robles-Campos5, Oszkar Hahn6, Matteo Serenari7, Elio Jovine8, Nadja Lehwald9, Wolfram T Knoefel9, Tim Reese10, Karl Oldhafer10, Martin de Santibañes11, Victoria Ardiles11, Georg Lurje12, Rafaela Capelli13, Marcelo Enne13, Francesca Ratti14, Luca Aldrighetti14, Alexey S Zhurbin15, Sergey Voskanyan15, Marcel Machado16, Yuki Kitano17, René Adam17, Nikita Chardarov18, Oleg Skipenko18, Valentina Ferri19, Emilio Vicente19, Koji Tomiyama20, Roberto Hernandez-Alejandro21.   

Abstract

BACKGROUND: Various, often conflicting, estimates for post-operative morbidity and mortality following ALPPS have been reported in the literature, suggesting that considerable center-level variation exists. Some of this variation may be related to center volume and experience.
METHODS: Using data from seventeen centers who were early adopters of the ALPPS technique, we estimated the variation, by center, in standardized 90-day mortality and comprehensive complication index (CCI) for patients treated between 2012 and 2018.
RESULTS: We estimated that center-specific 90-day mortality following treatment with ALPPS varied from 4.2% (95% CI: 0.8, 9.9) to 29.1% (95% CI: 13.9, 50.9), and that center-specific CCI following treatment with ALPPS varied from 17.0 (95% CI: 7.5, 26.5) to 49.8 (95% CI: 38.1, 61.8). Declines in estimated 90-day mortality and CCI were observed over time, and almost all individual centers followed this trend. Patients treated at centers with a higher number of ALPPS cases performed over the prior year had a lower risk of post-operative mortality.
CONCLUSION: Despite considerable center-level variation in ALPPS outcomes, perioperative outcomes following ALPPS have improved over time and treatment at higher volume centers results in a lower risk of 90-day mortality. Morbidity and mortality remain concerningly high at some centers.
Copyright © 2020 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32456975      PMCID: PMC7680722          DOI: 10.1016/j.hpb.2020.04.009

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  39 in total

Review 1.  Summary outcomes of two-stage resection for advanced colorectal liver metastases.

Authors:  Terence C Chua; Winston Liauw; Francis Chu; David L Morris
Journal:  J Surg Oncol       Date:  2012-05-30       Impact factor: 3.454

2.  Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression.

Authors:  Klaus Larsen; Juan Merlo
Journal:  Am J Epidemiol       Date:  2005-01-01       Impact factor: 4.897

3.  Failure to rescue as a source of variation in hospital mortality after hepatic surgery.

Authors:  G Spolverato; A Ejaz; O Hyder; Y Kim; T M Pawlik
Journal:  Br J Surg       Date:  2014-04-23       Impact factor: 6.939

4.  Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.

Authors:  Michael Linecker; Bergthor Björnsson; Gregor A Stavrou; Karl J Oldhafer; Georg Lurje; Ulf Neumann; René Adam; Francois-René Pruvot; Stefan A Topp; Jun Li; Ivan Capobianco; Silvio Nadalin; Marcel Autran Machado; Sergey Voskanyan; Deniz Balci; Roberto Hernandez-Alejandro; Fernando A Alvarez; Eduardo De Santibañes; Ricardo Robles-Campos; Massimo Malagó; Michelle L de Oliveira; Mickael Lesurtel; Pierre-Alain Clavien; Henrik Petrowsky
Journal:  Ann Surg       Date:  2017-11       Impact factor: 12.969

5.  Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Kerollos Nashat Wanis; Victoria Ardiles; Fernando A Alvarez; Mauro Enrique Tun-Abraham; David Linehan; Eduardo de Santibañes; Roberto Hernandez-Alejandro
Journal:  Surgery       Date:  2017-12-06       Impact factor: 3.982

6.  Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database.

Authors:  Jeffrey Phillip Jacobs; Sean M O'Brien; Sara K Pasquali; Marshall Lewis Jacobs; François G Lacour-Gayet; Christo I Tchervenkov; Erle H Austin; Christian Pizarro; Kamal K Pourmoghadam; Frank G Scholl; Karl F Welke; J William Gaynor; David R Clarke; John E Mayer; Constantine Mavroudis
Journal:  Ann Thorac Surg       Date:  2012-06-15       Impact factor: 4.330

Review 7.  Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios Moris; Sean Ronnekleiv-Kelly; Ioannis D Kostakis; Diamantis I Tsilimigras; Eliza W Beal; Alexandros Papalampros; Dimitrios Dimitroulis; Evangelos Felekouras; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

8.  Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons Learned from 15 cases at a single centre.

Authors:  S Nadalin; I Capobianco; J Li; P Girotti; I Königsrainer; A Königsrainer
Journal:  Z Gastroenterol       Date:  2014-01-13       Impact factor: 2.000

9.  Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?

Authors:  Roberto Hernandez-Alejandro; Kimberly A Bertens; Karen Pineda-Solis; Kristopher P Croome
Journal:  Surgery       Date:  2014-10-01       Impact factor: 3.982

10.  The comprehensive complication index: a novel continuous scale to measure surgical morbidity.

Authors:  Ksenija Slankamenac; Rolf Graf; Jeffrey Barkun; Milo A Puhan; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

View more
  3 in total

1.  Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales.

Authors:  Roland Brüning; Martin Schneider; Michel Tiede; Peter Wohlmuth; Gregor Stavrou; Thomas von Hahn; Andrea Ehrenfeld; Tim Reese; Georgios Makridis; Axel Stang; Karl J Oldhafer
Journal:  CVIR Endovasc       Date:  2021-05-17

2.  ALPPS and the endless pursuit of hepatic resectability.

Authors:  Matthew Byrne; Luis I Ruffolo; Roberto Hernandez-Alejandro
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

Review 3.  Induction of liver hypertrophy for extended liver surgery and partial liver transplantation: State of the art of parenchyma augmentation-assisted liver surgery.

Authors:  Philip C Müller; Michael Linecker; Elvan O Kirimker; Christian E Oberkofler; Pierre-Alain Clavien; Deniz Balci; Henrik Petrowsky
Journal:  Langenbecks Arch Surg       Date:  2021-03-19       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.